Your session is about to expire
← Back to Search
Enhanced Patient Navigation for Cancer Screenings
N/A
Recruiting
Led By Melissa Simon, MD
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Not cognitively impaired
Age 21 or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 18 months
Awards & highlights
Study Summary
This trial will test whether a new intervention can help patients with cancer screenings, counseling, and immunizations.
Who is the study for?
This trial is for adults over 21 living in specific Chicago areas (zip codes: 60605, 60607, 60608, 60609, 60616, 60623, 60632, or 60653), who identify as Chinese and can communicate in Cantonese, English, Mandarin or Toishanese. It's not for those unable to consent due to cognitive impairment or incarceration.Check my eligibility
What is being tested?
The study tests a 'Patient Navigation (PN) Checklist' designed to help cancer patients manage their health by focusing on social factors and ensuring they get the right screenings and immunizations.See study design
What are the potential side effects?
Since this intervention involves guidance rather than medication or medical procedures there are no direct physical side effects; however participants may experience stress or anxiety from discussing health-related issues.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am not experiencing any significant memory or thinking problems.
Select...
I am 21 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion, an average of 18 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 18 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Patient Receipt of Clinical Cancer Preventive Services and Resolution of Social Determinants of Health Barriers
Secondary outcome measures
Timeliness of diagnostic resolution
Timeliness of treatment initiation
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Group 2: Patient Navigation 2.0 ChecklistExperimental Treatment1 Intervention
The PN 2.0 Checklist intervention is centered on a learning health system checklist that enumerates a patient's Social Determinants of Health (SDoH) related barriers and tracks completion of services to address SDoH (at community oncology and community social service settings) as well as completion of USPSTF recommended cancer-related screenings, behavioral counseling, and immunizations.
Group II: Group 1: One-on-One Patient NavigationActive Control1 Intervention
One-on-one Patient Navigation will be based on a Case Management Model where patients navigators perform appointment scheduling and reminders; facilitate communication between patients and care teams; and identify and reduce patient barriers through education, outreach, and referrals to community, local, and state resources.
Find a Location
Who is running the clinical trial?
Northeastern Illinois UniversityOTHER
2 Previous Clinical Trials
250 Total Patients Enrolled
Northwestern UniversityLead Sponsor
1,587 Previous Clinical Trials
916,461 Total Patients Enrolled
Chinese American Service LeagueOTHER_GOV
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am not experiencing any significant memory or thinking problems.I am 21 years old or older.I can participate in a survey in Cantonese, English, Mandarin, or Toishanese.I am an adult who cannot give consent.I have difficulty with memory or thinking clearly.I am younger than 21 years old.
Research Study Groups:
This trial has the following groups:- Group 1: Group 1: One-on-One Patient Navigation
- Group 2: Group 2: Patient Navigation 2.0 Checklist
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any vacancies in this study for new participants?
"The clinical trial is currently ongoing, as seen on clinicaltrials.gov. This page was created on December 9th 2020 and updated April 18th 2021."
Answered by AI
How many individuals are being treated with this medication in this experiment?
"Yes, this clinical trial is still open and looking for patients. According to the information available on clinicaltrials.gov, the study was first advertised on December 9th 2020 and has since been updated on April 18th 2022. They are hoping to enroll 600 individuals at a single site."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger